Fubotv (FUBO) had the highest return between September 7, 2016 and October 7, 2016 by a US stock, returning 200%.
| ASSET | DATE | % RETURN |
|---|---|---|
Fubotv (FUBO) | 9/7/2016 - 10/7/2016 | 200% |
Clearside Biomedical (CLSD) | 9/7/2016 - 10/7/2016 | 189.23% |
Alpha Metallurgical Resources (AMR) | 9/7/2016 - 10/7/2016 | 160.87% |
Renovaro Biosciences (RENB) | 9/7/2016 - 10/7/2016 | 135.29% |
Matinas BioPharma (MTNB) | 9/7/2016 - 10/7/2016 | 129.41% |
Aurinia Pharmaceuticals (AUPH) | 9/7/2016 - 10/7/2016 | 124.88% |
Cronos (CRON) | 9/7/2016 - 10/7/2016 | 124.75% |
Nova Lifestyle I (NVFY) | 9/7/2016 - 10/7/2016 | 122.67% |
Aurora Cannabis (ACB) | 9/7/2016 - 10/7/2016 | 112.24% |
Sobr Safe (SOBR) | 9/7/2016 - 10/7/2016 | 111.11% |
Sarepta Therapeutics (SRPT) | 9/7/2016 - 10/7/2016 | 108.54% |
Corbus Pharmaceuticals (CRBP) | 9/7/2016 - 10/7/2016 | 106.11% |
Datasea (DTSS) | 9/7/2016 - 10/7/2016 | 103.33% |
Atlas Lithium Corporation Common Stock (ATLX) | 9/7/2016 - 10/7/2016 | 100% |
Merus (MRUS) | 9/7/2016 - 10/7/2016 | 96.61% |
Collegium Pharmaceutical (COLL) | 9/7/2016 - 10/7/2016 | 92.28% |
Alphatec (ATEC) | 9/7/2016 - 10/7/2016 | 80.4% |
Summit Therapeutics (SMMT) | 9/7/2016 - 10/7/2016 | 80.11% |
Bone Biologics (BBLG) | 9/7/2016 - 10/7/2016 | 80% |
InMed Pharmaceuticals (INM) | 9/7/2016 - 10/7/2016 | 75% |
Scynexis (SCYX) | 9/7/2016 - 10/7/2016 | 73.43% |
Curis (CRIS) | 9/7/2016 - 10/7/2016 | 71.07% |
Protagonist Therapeutics (PTGX) | 9/7/2016 - 10/7/2016 | 68.17% |
eXp World (EXPI) | 9/7/2016 - 10/7/2016 | 66.67% |
Processa Pharmaceuticals (PCSA) | 9/7/2016 - 10/7/2016 | 65.75% |
